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A fast, open source implementation of adaptive biasing potentials uncovers a ligand
design strategy for the chromatin regulator BRD4
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In this communication we introduce an efficient implementation of adaptive biasing that greatly
improves the speed of free energy computation in molecular dynamics simulations. We investigated
the use of accelerated simulations to inform on compound design using a recently reported and
clinically relevant inhibitor of the chromatin regulator BRD4. Benchmarking on our local compute
cluster, our implementation achieves up to 2.5 times more force calls per day than plumed2. Results
of five 1µsecond-long simulations are presented, which reveal a conformational switch in the BRD4
inhibitor between a binding competent and incompetent state. Stabilization of the switch led to
a -3 kcal/mol improvement of absolute binding free energy. These studies suggest an unexplored
ligand design principle and offer new actionable hypotheses for medicinal chemistry efforts against
this druggable epigenetic target class.
I. INTRODUCTION
Molecular dynamics (MD) simulations are often in-
voked within the context of drug discovery as a means to
score ligands by their absolute binding affinity.[1] In prac-
tice, MD simulations are also very useful in the discovery
process if they contribute testable hypotheses that guide
exploration of the chemical space around a ligand.[2, 3]
To be influential, simulations need to provide actionable
information on a short time scale, such that a team of
medicinal chemists cannot make the same discovery em-
pirically or find an alternative route to success before
simulation results are in hand.
The ability to explore the binding process and to com-
pute the free energy of binding within a relevant time
frame in silico depends on the rate at which the govern-
ing equations of motion can be propagated (Figure 1).
Standard MD is impractical for describing ligand-protein
binding/unbinding because more than 0.5 × 109 force
evaluations must be made before the simulation reaches
microsecond timescales. Meanwhile, effective ligands
may stay bound to their targets for tens of minutes[4].
With commonly used simulation tools, it takes about a
week to simulate a microsecond of a protein-ligand sys-
tem (Figure 3). Therefore, a considerable gap exists be-
tween the rate at which one can perform ligand bind-
ing simulations and the rate at which empirically driven
progress can be made in a drug discovery setting.
A recent approach to tackle this problem of
timescales has been the construction of very specialized
computers[5, 6], which has generated some long trajecto-
ries of ligand binding[7, 8]. These specialized computers
aim to make as many MD cycles per unit time as pos-
sible. An alternative, more easily dispersed approach is
the use of algorithms that leverage formalities of statisti-
cal mechanics to extract as much information as possible
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FIG. 1: A basic schematic of the MD propagation cycle before
(left) and after (right) the addition of an adaptive biasing
potential. The number of trips around the cycle per unit
time expresses the speed of MD simulation.
from every iteration of the MD cycle. This approach
aims to reduce the number of cycles required to estimate
thermodynamic quantities such as free energy of binding.
In this study, we focus on the use of adaptive biasing
potentials (ABP) to increase the efficiency of free energy
calculations and conformational exploration. ABP meth-
ods supplement the system energy in a time-dependent
manner so that metastable states are slowly flooded with
energy until they are flattened away. The flooding leads
to new forces that are contributed by a time evolving
biasing potential Vb (Figure 1).
In the MD cycle depicted in Figure 1, ABP methods
introduce computational overhead in evaluation of the bi-
asing force, and thus slow the rate of completing the MD
cycle. While native MD engines are typically faster at
making cycles, ABP schemes improve the statistical value
of each cycle by several orders of magnitude. The exact
improvement of statistical efficiency can be expressed as
the ratio of unbiased to biased partition functions, which
quantifies exactly how the ABP schemes improve sam-
pling efficiency by shrinking the Boltzmann-weighted vol-
ume of configuration space.
Given the statistical advantage brought about by ABP,
the inefficiency of the associated MD cycle is often taken
for granted. Here we show that by minimizing ABP net-
work communications within the MD engine and by min-
2imizing computational complexity of the ABP scheme,
the efficiency of the biased MD cycle can be drastically
improved while maintaining the statistical advantage of
ABP. On our local compute cluster, we show efficiency
gains of 25% to 67% over the commonly used plumed2[9]
plugin. In Amazon’s elastic cloud computing environ-
ment, we demonstrate a 36% improvement in the MD
cycle rate for a 26% reduction of simulation costs com-
pared to the same plumed2 plugin. These improvements
reduce the time gap between in silico and in vitro drug
discovery, and increase the affordability of high through-
put cloud applications. In light of the expanding ABP
usage base, these efficiency gains can also be projected
to generate substantial savings and an improvement in
simulation scope for the computational community.
As an example application, the results of 4
microsecond-long simulations of a ligand-protein sys-
tem are reported for a clinically relevant inhibitor[10]
against the chromatin regulator BRD4 (bromodomain-
containing protein 4). Three of these simulations were
allowed to sample the full surface of the protein and 60%
of the simulation volume to fully detail the protein-ligand
interaction. These simulations show several metastable
states where the ligand aggregates on the protein surface
and suggest that better control over a ligand conforma-
tion change could improve affinity. The current ligand
scaffolds present two conformations, only one of which is
binding competent.
Without the efficiency gains derived below, each one of
the µs-long simulations presented in this work would have
taken 5.3 days longer to complete on exactly the same
computer hardware had the current gold standard ABP
software been used. Had all of the simulations been run
in serial, they would have taken an extra 21 days to com-
plete. In Amazon’s elastic cloud computing environment,
the simulations presented below would cost an additional
$1200 USD without the time-saving advances described
here. Extrapolating these savings to the MD community
projects years of saved compute time and tens of thou-
sands of dollars. Thus, the implementation described
below positively impacts computational throughput and
better optimizes the dollars spent funding computational
research.
II. RESULTS AND DISCUSSION
The efficiency of the ABP implementation has been im-
proved by considering two sources of computational over-
head: (1) Computational complexity of the bias potential.
In our implementation, the master node of the simulation
handles the bias updates and bias force evaluation which
is a concern for load balancing. Thus, a major advance
in this implementation model has been the reduction of
computational complexity within the bias itself. We have
written the bias in terms of kernels, or “hills,” that have
compact support (Figure S1). These new hills result in a
significant reduction of operations (namely reduced mem-
ory accesses and multiplies) when the bias is updated,
leading to better load balancing. Others have also used
truncated kernels to reduce complexity[11] and below we
demonstrate that this one aspect of the implementation is
not enough to ensure good scalability. (2) Minimization
of communications introduced by the ABP scheme. In
ABP schemes, a collective variable (CV) must be com-
puted. The CV is a coarse-grained description of the
system state, and as such, it requires atomic positions.
In most modern MD engines, the master node does not
know all of the current atomic positions, so some commu-
nication is required. Additionally, once the master node
computes the biasing force, that force must be communi-
cated back to the nodes that are managing atoms in the
CV. Details regarding each of these aspects of develop-
ment are given in the SI.
We implemented two bias potentials, with the default
being mollified adaptive biasing potential (mABP)[12].
This bias potential was derived elsewhere[12, 13] and has
been shown to recover well-tempered metadynamics[14]
under an approximation that destroys the mollifying
properties of the bias[13]. Importantly, mABP is not a
form of metadynamics. Reference 13 shows that while
mABP defines the bias potential as the log of a his-
togram of sampling, all forms of metadynamics write the
bias potential as directly proportional to a histogram
of sampling. Following from this, a key attribute of
mABP is that the biasing force is an ensemble aver-
age quantity. The metadynamics family tend toward
higher computational complexity than mABP. Bound-
ary corrections[15, 16], for example, are not required in
mABP and are not supported in this distribution. Con-
vergence behavior for mABP and well-tempered metady-
namics (WTmetaD) are reported in Supplemental Mate-
rial for alanine dipeptide to test functionality with the
compact hills (Figure S2).
It is known that metadynamics places strict condi-
tions on the hill functions[17] and that the convergence
time of metadynamics scales exponentially with the hill
width[13]. We observed a parameter dependent sensi-
tivity to artifacts for the well-tempered metadynamics
method when using the hill functions introduced in this
work (Figure S3). Artifacts could be observed when WT-
metaD was used to repeat the simulations described be-
low as well, though the artifacts were much more difficult
to diagnose. Therefore, we do not recommend invoking
the metadynamics method with the hills implemented
here. WTmetaD performs well for some hill settings but
not for others, leaving open the possibility of undiagnosed
failures when using the method.
A. Timing of the implementation for a practical
application
An application to ligand binding is given here to
measure overhead of the new implementation and as a
demonstration of the mABP method. The model sys-
3FIG. 2: (Left) PDB entry 5hm0 is shown with the ligand in
green sticks. (Right) The 5hm0 entry is shown again where a
clipping plane is used to expose the entire ligand.
tem involves a recently reported, clinically relevant, small
molecule which binds the first bromodomain of BRD4[10]
(PDB:5hm0). BRD4 is an acetyllysine binding protein
that is emerging as a therapeutic target for controlling
expression of the “undruggable” oncogenic transcription
factor MYC[18]. Inhibitors like the one simulated here
are part of an emerging class of epigenetic-based thera-
peutics being tested clinically for the treatment of haema-
tological malignancies.[19] The lead ligand (compound 3
of reference 10) in complex with bromodomain 1 of BRD4
is shown in Figure 2.
A pair of RMSD CVs were chosen for the simulations.
One CV is the RMSD between a subset of atoms in the
ligand at its current (simulated) position and the Xray
structure. The second CV is the RMSD between a dif-
ferent subset of ligand atoms in its current (simulated)
position and the Xray. This set of CVs projects the full
ligand-accessible space onto the diagonal of the CV space
because the two CVs are tightly coupled (Figure S4). The
base GROMACS input topologies and tpr files for equi-
libration were built according to the swissparam tutorial
for preparing GROMACS topologies[20]. Everything re-
quired to re-run these biased simulations (all simulation
parameters and inputs), including a general tutorial for
using the ABP code, can be found at the GitHub page for
this project.[21] The tutorial itself allows one to perform
simulations of this ligand-protein system.
The performance of our ABP implementation is com-
pared against native GROMACSv5.0.5 and native GRO-
MACSv5.1 for several numbers of compute cores. Be-
cause the implementation builds on the GROMACS
package, we call it fABMACS for fast Adaptively Biased
MAchine for Chemical Simulations. The data shown
in Figure 3 were selected to minimize oscillations in
the scaling of the native GROMACS codes, representing
the envelope of best performance for the native GRO-
MACS MD engine. In all cases, GROMACS was allowed
to choose the partitioning of PME and particle-particle
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FIG. 3: (Top) Nanoseconds per day as a function of compute
cores for GROMACS, mABP (fABMACS), and plumed2.
(Bottom) Percent efficiency relative to native GROMACS as
a function of cores. All data points are an average of three
runs.
nodes and in all cases we verified that all the data at a
particular node count were collected with the same par-
titioning. For the fABMACS simulations, the CV space
was discretized into a 480 by 480 bin grid with an RMSD
range from 0 to 12 nanometers. Although irrelevant for
timing, the biasing parameters were c = 0.001, b = 0.9.
A range of hill widths were considered, and the temper-
ature was 300 Kelvin. Results are reported in units of
nanonseconds per day, which can be converted to the
number of MD cycles per day by multiplying by 500000
(the MD timestep was 0.002 fs). See SI section 1 for the
definition of the hill functions, Spa . The parameter a fixes
the width of the hill and p alters the shape. Section 3 of
the SI covers how to think about these hills in terms of
the more common Gaussian hill.
Figure 3 also shows the performance of the plumed2[9]
plugin running WTmetaD, which was plugged in to
GROMACSv5.1. The fABMACS parameters were con-
verted to well-tempered metadynamics parameters ac-
cording to reference [13] and the hill width used with
plumed was within the range of widths shown for fAB-
MACS. The CV and CV discretizations were identical for
the plumed2 and fABMACS methods. All of the various
GROMACS codes were compiled with the same config-
urations on the same hardware. We did not observe in-
efficiency when running WTmetaD in fABMACS. WT-
metaD introduces three extra multiplies per grid point
during the bias update (to scale hill heights for the po-
tential and its forces), and one exponential evaluation
(to determine the hill height). On 72 cores, our imple-
mentation of WTmetaD (without boundary corrections)
averaged only 1 ns/day less than mABP.
Our ABP implementation presents minimal overhead
to the underlying GROMACS engine, and the scalabil-
ity of GROMACS is intact. For this system, fABMACS
4TABLE I: Amazon Elastic Compute Cloud Results, and cost
in USD/µs and days/µs.
Software Biased ns/day $(USD)/µs Days/µs
GROMACSv5.1 no 82.027 $760 12.2
fABMACS yes 78.136 $798 12.8
plumed2 yes 57.449 $1086 17.4
achieves a maximum of 125 ns/day on 72 compute cores
spanning three different machines. The maximum of the
native GROMACS code is 134 ns/day on 72 cores. It can
be appreciated, as expected, that the extra ABP-related
communications are slowing down the simulation as the
number of cores is increased (Figure 3; bottom).
Given the rise of cloud computing, it is pertinent
to consider timings in the cloud environment as well.
GROMACSv5.1, plumed2, and fABMACS were timed in
Amazon’s EC2 environment using “g2.8xlarge” compute
nodes. These nodes have 32 cores and four Nvidia GRID
GPUs. The cost of this EC2 instance is currently $2.60
USD per hour. Table I shows the cost per microsecond
for native GROMACS, fABMACS, and plumed2 based
on timings of 100000 MD steps. Note that both plumed2
and fABMACS should be expected to generate better
sampling than native GROMACS, due to the shrinking
partition function, even though native GROMACS is the
least expensive per force call. Running fABMACS costs
$38 USD more per microsecond than native GROMACS,
while plumed2 costs an extra $326 USD per µs. We did
not run simulations spanning multiple machines in the
cloud because projected costs did not suggest any bene-
fit.
Encouraged by the performance of the application
tested above, we also tested the performance of the built-
in NAMDv2.11[23] and AMBERv16.05[24, 25] implemen-
tations of adaptive biasing potentials for a larger uni-
versal benchmark. The benchmark system is a small
peptide in water, producing a 99k atom system.[22] All
collective variables were 2 RMSDs to an initial position
with each CV having four atoms. Figure 4 reports re-
sults similar to what others have observed for unbiased
simulations.[26, 27] Here, we have used 28 cores spread
across 7 nodes and to gain insight to the performance
of the different MD packages we watched the network
communications on the master node of the simulations
via ifconfig. The cumulative inbound traffic is shown in
Figure 4(Bottom) for each MD package. All machine in-
terconnects were 40GbE.
Figure 4(Bottom) suggests that PLUMED2 is ineffi-
cient within the bias update and bias force computations
but not in network communications. This may be a load
balance issue. The built-in NAMD biasing seems limited
by the underlying speed of NAMD. The pmemd-AMBER
implementation appears to produce excessive network
traffic when ABMD is invoked. Activation of biasing
within AMBER on GPU also incurs efficiency losses ei-
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FIG. 4: Universal benchmark using 99,137 atoms for adap-
tive biasing of two 4-atom CVs, in the canonical ensemble
with partical mesh Ewald and periodic boundaries.[22] (TOP)
Nanoseconds per day for different MD packages on CPU or
GPU. (BOTTOM) Network traffic on a node for MD packages
when distributed across 7 compute nodes.
ther because excessive system information is passed from
the GPU to CPU for biasing at every timestep or be-
cause CPU speed is a bottleneck. As we noted earlier,
this demonstrates that minimization of operational com-
plexity in the bias[11] is insufficient to achieve good scal-
ability although it is required for load balancing.
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B. Applications to ligand binding
The fABMACS package can be compiled for different
scenarios. To keep the code as streamlined as possible, a
number of options are hard-coded via a patching script.
The script sets a number of parameters for things like CV
space discretization, selection of mABP or WTmetaD,
and what type of restraint system to apply. There are
two selectable restraint types, a spherical or cylindrical
restraint. There is a third restraint that cannot be de-
selected, which limits the maximum value of the CVs.
This restraint can be obsoleted by setting a large max-
imum limit. A full tutorial is available on the project
GitHub page[21], which walks through setting up and
running the simulations presented in this section. The
periodic simulation boundaries are unwrapped such that
the ligand is whole and such that the ligand does not
“jump” across the box. Unwrapping is not supported in
some ABP plugins[28], yet unwrapping is critical unless
the simulation system is designed such that the CVs are
never broken by periodicity.
We performed a total of four 1µs simulations with the
lead ligand that used the spherical (Figure 5A) or cylin-
drical (Figure 5B) restraint. The mABP simulations used
hills with compact support , called Spa , where p = 20 and
a = 10×∆ξi or p = 20 and a = 20×∆ξi, where the latter
is labeled “wide” in Figure 5D. Plots of free energy for
all of the simulations are shown in 2-dimensions (Figure
S4) and as 1-dimensional projections (Figure 5D). We
followed the formalisms of References 29 and 30 for es-
timating absolute binding free energy with and without
restraints, respectively.
The absolute free energy of binding estimated from
each of the simulations ranges from -5.18 to -7.63
kcal/mol. All of the estimates are within 4 kBT of one an-
other, where kB is Boltzmann’s constant and T is temper-
ature. This is a surprising degree of similarity given that
three of the simulations were allowed to sample the entire
protein surface, and two of those started in an unbound
conformation. In each of the simulations using wide hills
and the large spherical restraint, the crystallographic lig-
and pose was found only once. One of these simulations
started in the bound conformation, one started in an un-
bound conformation. Both simulations found the crystal-
lographic pose from an unbound state. In the simulation
using narrow hills and starting in an unbound conforma-
tion, the crystallographic ligand pose was found twice.
(Figure S6) Simulations as loosely restrained as these are
6very rarely performed and have even been described as
impossible.[29] Indeed, we only tried these simulations af-
ter being encouraged by the performance of fABMACS.
The simulation using the cylindrical restraint found the
crystallographic pose four times. Thus, the free energy
estimate from the cylindrical restraint is expected to be
most accurate.
The average absolute free energy of binding over the
four estimates is -6.56 kcal/mol with a standard error of
0.56 kcal/mol. The free energy estimate from simulation
with the cylindrical restraint was -6.16 kcal/mol. We did
not compare to binding free energy estimated from IC50
reported in Reference 10 for two reasons. First, we did
not parameterize the ligand via ab initio methods. Sec-
ond, the binding constant of the competitor ligand must
be known to make an accurate free energy estimate[31],
and details of the competitor ligand were not reported.
It is also worth noting that most ligand development
efforts focus on dissociation constants rather than free
energy of binding. If simulation estimates leave a 1
kcal/mol error in the free energy, there is a 5-fold er-
ror in the dissociation constant. For a 2 kcal/mol error
in the free energy, there is a 29-fold error in the disso-
ciation constant. In general, it is more informative to
generate structure-activity trends than to compare sim-
ulation results to experimental metrics.
The simulations using the spherical restraint sample
a number of configurations where the ligand is aggre-
gated to the protein surface (Figure 5C). We observe a
large number of states where the ligand is aggregated
on the ZA-loop or docked in the binding pocket with
an incorrect pose. Most binding pathways show the lig-
and aggregate to the pocket or ZA-loop and then explore
different ligand poses and azepine ring conformations un-
til the crystallographic pose is found. Often, the ligand
leaves the pocket area and moves back into solvent before
finding the correct pose.
Many attempted binding events were rejected by the
protein because the ligand adopted a binding incom-
petent conformation. The benzoisoxazoloazepine ligand
contains an azepine ring that can adopt different pucker-
ing states; (Figure S5) only one of the two major puck-
ering states is consistent with the crystallographic pose.
The “incorrect pose” shown in Figure 5C is representa-
tive of a state in which the azepine ring has adopted a
conformation inconsistent with the crystallographic pose,
precluding correct binding and slowing the binding pro-
cess.
As a simple means of testing the hypothesis that
binding could be improved by reducing flexibility of
the azepine ring, we computed the binding free energy
again while applying a dihedral restraint that prevents
the azepine from changing conformations. The absolute
binding free energy, computed from a 1µs simulation us-
ing the cylindrical restraint and an inflexible azepine, was
-9.42 kcal/mol. This compares to -6.16 kcal/mol for the
flexible azepine in the cylindrical restraint (Figure 6).
The restrained ligand found the crystallographic pose 6
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FIG. 6: Binding landscapes without (left) and with (right) a
rigid azepine. Contours are every 2kBT from 0 to 40 kJ/mol.
times (Figure S6). These simulations validate our hy-
pothesis and motivate ligand chemistry that would re-
strain the azepine. Functionalization of the ligand or
abandonment of the azepine ring are both plausible di-
rections.
III. CONCLUSION
We have introduced and benchmarked an implemen-
tation of ABP in GROMACS 5.0.5, called fABMACS,
that presents minimal overhead to the GROMACS en-
gine. The implementation strives to maintain the scala-
bility of GROMACS. A minimal communication scheme
and local smoothing kernels have been used to achieve
this goal. Drastic efficiency gains were demonstrated, as
compared to the most common alternative ABP plugin.
The fABMACS code is available on GitHub[21] where
a tutorial can also be found. All of the ligand-protein
simulations presented above can be re-run by following
the tutorial. Currently, only RMSD CVs are supported,
but a range of systems should be compatible with this.
A future goal is to develop the distribution to support a
range of different CVs. Cylindrical, spherical, and sim-
ple range-limiting CV restraints are supported. A build
script is included with the code, which customizes source
code for user specifications of methods, restraint types,
restraint scales, and so-on. Thus, if a user can install
GROMACS 5.0.5 on their compute infrastructure, then
fABMACS can be installed using the same configuration.
Simply run the build script with specified options, and
compile the source code as normal. Implementation into
other MD engines are also ongoing.
The results of long simulations of the first bromod-
omain of BRD4 with a clinically-relevant small molecule
were presented, both to make methodological demonstra-
tions using mABP and to examplify structural insights
that are obtained from atomistic simulations. Simula-
tions were presented that found the bound state after
having escaped, even when the full surface of the protein
could be sampled. We suggest a trend in the published
SAR data that could be further exploited to improve po-
tency — Namely the azepine ring affords conformational
freedom that reduces ligand efficiency.
fABMACS will be useful in identification of false pos-
7itives, creation of chemical hypotheses, scoring ligands,
and guiding NMR based fragment screening. The effi-
ciency gains of fABMACS will enable more efficient use
of computational resources and make new, ambitious ap-
plications more affordable and tractable.
IV. SUPPLEMENTAL MATERIAL: A FAST,
OPEN SOURCE IMPLEMENTATION OF
ADAPTIVE BIASING POTENTIALS UNCOVERS
A LIGAND DESIGN STRATEGY FOR THE
CHROMATIN REGULATOR BRD4
A. Streamlined bias potential updates
Let the CV be ξ which is a vector of coordinates in the
CV space, and let ξ∗ be a particular point. We use xt
to indicate the position of the trajectory in configuration
space, and ξ(xt) or ξt to indicate the trajecotry position
in CV space. The mABP bias potential is
Vb(ξ, t) = β
−1 b
1− b
ln[c (1− b)hα(ξ, t) + 1] (1)
and the mABP bias gradient is
∂Vb(ξ(xt), t)
∂ξi
=
c b β−1 h′i,α(ξ
∗, t)
1 + c (1− b)hα(ξ∗, t)
(2)
where β−1 = kBT is the temperature of the simulation
in units of energy. b and c are parameters, as discussed
in the Appendix (or SI). Two histograms are required for
evaluating the biasing force
hα(ξ, t) =
∫ t
0
δα(ξ(xs)− ξ) ds
h′i,α(ξ, t) =
∫ t
0
∂ξiδα(ξ(xs)− ξ) ds
(3)
The first is a standard histogram convoluted with a
smoothing kernel, or “hill”,
δα(ξ) = exp
(
−
|ξ|2
α2
)
(4)
where α controls the width of the Gaussian. The sec-
ond histogram is actually the weak derivative of the raw
(un-smoothed) histogram along ξ. One can appreciate
that if the histograms are collected, the biasing force re-
quires only a look-up in the histograms and some arith-
metic operations. As we have advocated in the past[32],
this is also much more simple than adaptive biasing force
methods[33, 34].
In order to collect these histograms with computer
code, the CV (and time) must be discretized. Let the
discretization use Nbins for each dimension of the CV
space. Ignoring the trivial details, the position of the
trajectory is then approximated by the nearst grid point
ξ∗ ≈ ξ(xt) and the histograms are updated as
hα(ξ, t+∆t) = hα(ξ, t) + δα(ξ
∗ − ξ)
h′i,α(ξ, t+∆t) = h
′
i,α(ξ, t) + ∂ξiδα(ξ
∗ − ξ)
(5)
for all grid points ξ at every timestep of the simula-
tion with the initial conditions h(·, t = 0) = 0 and
h′(·, t = 0) = 0. (∆t is the MD timestep) The hills
(or smoothing kernels) are stored in a lookup table (see
reference 13) by precomputing δα(ξ
∗ − ξ) for every pos-
sible pair (ξ∗, ξ) in the discretized CV space. Thus the
Gaussians δα are evaluated once and only once. How-
ever, because the Gaussian hills do not vanish, the up-
date in equation (5) is made for all grid points. In order
to greatly reduce the number of arithmetic operations in
equation (5), one can introduce smoothing kernels that
have compact support. Such kernels would only be non-
zero in the neighborhod of ξ∗ so that an update only
needs to cover a small subset of the grid points repre-
senting the CV space.
For each component of the CV ξi, the compact smooth-
ing kernels have the form (see figure 7)
Spa(ξi) =

ep × e
(
−p
1−|
ξi
a
|2
)
if | ξia | < 1
0, otherwise
(6)
where the leading p factors of e ensure that Spa(ξi = 0) =
1 and the parameter a controls the width of the function.
To further minimize complexity, we define the smoothing
kernel in a multi-dimsional CV space as the product of
these one dimentional functions. The integer 1 ≤ p al-
lows the resulting multidimensional function to be round
rather than square. (Increasng p makes the functions
more round.) With these compact functions the update
becomes
ha(ξ, t+∆t) = ha(ξ, t) + S
p
a(ξ
∗ − ξ)
h′i,a(ξ, t+∆t) = h
′
i,a(ξ, t) + ∂ξiS
p
a(ξ
∗ − ξ)
(7)
where the update only runs over grid points near ξ∗, such
that Spa(ξ
∗ − ξ) > 0, i.e., those grid points within a dis-
tance a from the trajectory at ξ∗. The WTmetaD update
can be written in analogy with the mABP update, with
the only difference being that WTmetaD scales the up-
date in equation (7) by a factor determining the so called
“hill-height”. The value a may be different for different
components of ξ although this case is not covered here.
For a multidimensional CV space this results in a large re-
duction of evaluations at each bias update. In two dimen-
sions, we replace Nbin2 operations with Nbase2 opera-
tions where Nbase is the number of grid points spanned
by Spa . All the analysis of mABP from reference 12 holds
with these new functions so the method will converge, as
we next demonstrate.
B. Minimization of Interprocess Communications
To minimize communications, each processor checks if
it is responsible for any atoms in the CV. If a processor
does manage CV-implicated atoms, it sends a flag to the
master processor to indicate this, and it sends a vector
8to the master which holds those atom’s coordinates. If
a processor does not manage atoms in the CV, then it
sends a flag to indicate this. The master now knows
which processors are involved in CV and which processors
are not, and recieves the atom coordinates from those
processors that are involved in the CV. The master then
passes the atomic coordinates (of only those atoms in
the CV) to the mABP routine which computes the bias
update and bias force. The master then sends the bias
force back to the processors that have atoms involved in
the CV, where each processor then adds the biasing force
to the GROMACS force for its atoms.
This communication scheme was implemented by in-
jecting MPI (message passing interface) function calls
in the md.c routine of GROMACS. The GROMACS
ga2la get function was used to determine which atoms
are “home” atoms for each process. The “home” atoms
that are in the CV are the atoms that must be sent to
the master for adaptive biasing. All of the additional
code, save initializations, was injected after the call to
do force. Our biasing routine is written in fortran and
named “hellof”, meaning “hello fortran.” The biasing
function as well as the fortran compilation option were
specified in the CMakeLists.txt file of the mdrun direc-
tory. No other changes to GROMACS were required.
C. Convergence with Spa
The usual alanine dipeptide benchmark is used here
to demonstrate convergence for this new smoothing func-
tion. Exactly the same set-up for measuring convergence,
the same reference free energy, and the same biasing pa-
rameters (c and b) are used as recently reported[13].
The CV space here is two dimensional, and each com-
ponent is a backbone dihedral angle, one CV for ψ and
one for φ. In Figure 7, we plot S118(ξ1), where ξ1 is one of
the dihedral angles. Using a = 18 scales the domain of S1a
so that the kernel is zero when the dihedral angle is more
than 18 degrees from 0. The compact hill S1a is shown in
purple, while the more typical Gaussian hill is shown in
black. The width of the two hills at half-height is iden-
tical, and we suggest that the width at half-height is a
reasonable way to get some intuition for these smoothing
kernels as compared to the Gaussian kernels.
The width at half-height for Spa is given by
wa = 2 a
√
ln(2)
p+ ln(2)
(8)
The base of Spa has a width of 2a, and a bin-width of
Nbase = 2a/∆ξi where ∆ξi is the distance between grid
points for the i-th CV. For equation (4), one can write
the α for which δα has the same width at half-height
α = wa/(2
√
ln(2)). This allows one to have a feeling for
how Spa compares to a more familiar Gaussian smoothing
kernel. The Gaussian in Figure 7 uses α = 13.833.
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FIG. 7: Compact hill (purple) with a Gaussian hill (black).
In Figure 8, error in the free energy estimate is shown
as a function of simulation time for different values of a.
The error is the average absolute difference between the
ABP (either mABP or WTmetaD) free energy estimate
and a reference free energy, as described in reference 13
One of the strengths of mABP was that it leads to a free
energy estimate that is independent of α.[12] When us-
ing these new kernels, the free energy is independent of
a, as can be seen in Figure 8. WTmetaD, on the other
hand, seems to be more sensitive to these hills than it is
to Gaussian hills. Figure 8 reflects this, showing an im-
paired convergence for a hill that compares to a Gaussian
of about 20 degrees. We’ve recently looked in detail at
how metadynamics is impaired when the hill widths are
large[13], where we showed WTmetaD converges quickly
until the Gaussian hill widths are greater than 30 degrees.
The Spa hills have a boxy shape in 2D. The parameter
p allows them to be rounded out. The results in Figure
8 used p = 20. The problem for WTmetaD is that we
do not know how to set p and a for an arbitrary system
in a way that will guarantee sufficiently round hills. The
WTmetaD method demonstrates a failure to converge
on the timescales we tested when p = 1 and it demon-
strates pathological sampling behaviors. Figure 9 shows
the histogram of backbone dihedral angles that was col-
lected from WTmetaD and mABP using the same hills
(base width 24 degrees and p = 1). While it is possible
to choose functional hills for WTmetaD, it is impossi-
ble to know a priori which hills will fail. mABP, on the
other hand, exhibits robust performace. We stress that
increasing p salvages the WTmetaD simulations but a
general rule for identifying failure is not in-hand. In the
mean time, we advocate sticking to mABP while using
fABMACS.
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FIG. 8: (Top) Free energy landscape from mABP where the
base-width of Sp=1a was 72 degrees. (Bottom) Convergence of
alanine dipeptide with compact hills for different base widths
(2a) in units of degrees. (all p = 20)
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FIG. 9: Histograms of the trajectory sampling for WTmetaD
and mABP with the same hill settings. WTmetaD shows a
corrugated pattern while mABP shows a smoother sampling.
D. Ligand Binding
The free energy landscapes for the four mABP simu-
lations are shown in Figure 10. The tightly coupled CVs
project the configuration space onto the diagonal of the
CV space.
In Figure 11 we show the free energy landscape of the
ring puckering for both the lead and final compounds
from reference 10. Indeed, the immediate and testable
Wide hill, starting unbound Wide hill, starting bound
Narrow hill, starting unboundNarrow hill, cylindrical restraint
C
V
-1
CV-2
k
J
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FIG. 10: Landscapes from ligand binding.
hypothesis suggested by these simulations is that this
puckering behavior could be controlled to improve po-
tency. The compound on the right side of figure 11 is
CPI-0610, which is the compound that has moved into
clinical trials. Of course, binding is not the only con-
sideration when the goal is development of a drug, and
this compound was ultimately selected for its favorable
pharmacokinetics and toxicological profiles.
Lead compound
Binding competent
Binding incompetent
Candidate drug
FIG. 11: Landscape of the azepine pucker. The CV were di-
hedrals, as indicated pictorially. The crystallographic geom-
etry is given by the upper left minimum on the landscapes.
Simulations were 300 ns long and swissparam was used to
parameterize the ligands. Contours are every 2kBT .
E. Definition of the RMSD
To avoid division by zero when the RMSD is zero, we
write the RMSD as
RMSD(x, x0) =
(
1
N
N∑
i=1
(x(i) − x0(i))
2 + 0.01
)1/2
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which is offset from zero by 0.01. x are the atomic po-
sitions of the atoms in the CV and x0 are the refer-
ence positions for the atoms. The lower bound for this
RMSD is 0.1. A trace of CV1 for all trajectories shows
that the RMSD is 0.1 when the crystallographic state
is found (Figure 12). Sim1 started unbound in spher-
ical restraint, sim2 started bound and used the spheri-
cal restraint, sim3 started unbound and used spherical
restraint, sim4 started bound and used cylindrical re-
straint. The rigid azepine simulation started bound and
used the cylindrical restraint.
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FIG. 12: Traces of CV1 for all simulations. The pink bar
highlights the crystallographic state. See text for details.
V. SUPPLEMENTARY MATERIAL
Supplementary material provides details on the hill
functions, MPI calls in GROMACS, convergence results
for alanine dipeptide, free energy landscapes for ligand
binding simulations, free energy of azepine conforma-
tions, and the definition of our RMSD coordinate.
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